- 询价
- 辰辉创聚生物®️
- 中国
- NBL-293986
- 2026年05月19日
相关产品推荐更多 >
重组人LY6D蛋白 | Recombinant Human LY6D, 21-98aa, His-tag
询价重组人KLK3蛋白 | Recombinant Human KLK3, 25-261aa, His-tag
询价
重组小鼠Shh蛋白 | Recombinant Mouse Shh, 25-198aa
询价重组人Scavenging Receptor SR-BI蛋白 | Recombinant Human Scavenging ReceptorSR-BI, 33-443aa, His-tag
询价
重组人DSG3蛋白 | Recombinant Human DSG3 Protein, 50-615aa, Fc-tag
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
阿拉丁试剂，充足现货，稳定批间差Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human CD268/TNFRSF13C Protein, 2-71aa, His-tag
中文名称：重组人CD268, TNFRSF13C蛋白
别名：Tumor necrosis factor receptor superfamily member 13C, B-cell-activating factor receptor, BAFF receptor, BAFF-R, BLyS receptor 3, CD268, TNFRSF13C, BAFFR, BR3
货号：NBL-293986
品牌：辰辉创聚生物®️
规格：100UG; 1MG; Bulk
| 产品描述
NebuSelect™ Recombinant Human CD268/TNFRSF13C Protein, His-tag (Cat# NBL-293986) is expressed in HEK293 Cells with His Tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species: Human
Expression System: HEK293 Cells
Molecular Weight: 11 kDa
Target Name: CD268, TNFRSF13C
Purity: >90% by SDS-PAGE.
Formulation: See COA
Endotoxin: ＜1 EU/ug(LAL Method)
Storage: 4°C for short term; -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验GPI蛋白 本文提供了有关糖基磷脂酰肌醇（GPI，是许多蛋白以及病毒蛋白结合于膜上的锚点）的信息。同时，网站还提供了许多相关链接和资源。 GPI overview GPI proteins in chickens GPI proteins in Drosophila GPI in prion proteins Human GPI proteins: protectin (CD59) and homologous restriction factor (HRF
Assessing Fc Glycan Heterogeneity of Therapeutic Recombinant Monoclonal Antibodies Using NP-HPLC
Recombinant monoclonal antibodies (rMAbs) are becoming major human therapeutics to treat life-threatening diseases such as cancer. These rMAbs are produced using either in vitro cell culture processes or transgenic technology in animals
) in any given fraction have relevance to any human disease? If the protein has no obvious use as a drug target, it is ignored. If the protein is deemed relevant, one immediately has a lead molecule and a defined target. In cases where a single protein is eluted
技术资料暂无技术资料 索取技术资料
